Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 175

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers

Open access
Rajput, Ashish B, Miller, Melinda A, De Luca, Alessandro, Boyd, Niki, Leung, Sam, Hurtado-Coll, Antonio, Fazli, Ladan, Jones, Edward C, Palmer, Jodie B, Gleave, Martin E, Cox, Michael E, Huntsman, David G·2007·Journal of Clinical Pathology

Abstract

Background: Recent reports indicate that prostate cancers (CaP) frequently over-express the potential oncogenes, ERG or ETV1 . Many cases have chromosomal rearrangements leading to the fusion of the 5′ end of the androgen-regulated serine protease TMPRSS2 (21q22.2) to the 3′ end of either ERG (21q22.3) or ETV1 (7p21.3). The consequence of these rearrangements is aberrant androgen receptor-driven expression of the potential oncogenes, ETV1 or ERG . Aim: To determine the frequency of rearrangements involving TMPRSS2 , ERG , or ETV1 genes in CaP of varying Gleason grades through fluorescence in situ hybridisation (FISH) on CaP tissue microarrays (TMAs). Methods: Two independent assays, a TMPRSS2 break-apart assay and a three-colour gene fusion FISH assay were applied to TMAs. FISH positive cases were confirmed by reverse transcriptase (RT) PCR and DNA sequence analysis. Results: A total of 106/196 (54.1%) cases were analysed by FISH. None of the five benign prostatic hyperplasia cases analysed exhibited these gene rearrangements. TMPRSS2:ERG fusion was found more frequently in moderate to poorly differentiated tumours (35/86, 40.7%) than in well differentiated tumours (1/15, 6.7%, p = 0.017). TMPRSS2:ETV1 gene fusions were not detected in any of the cases tested. TMPRSS2:ERG fusion product was verified by RT-PCR followed by DNA sequencing in 7/7 randomly selected positive cases analysed. Conclusion: This study indicates that TMPRSS2:ERG gene rearrangements in CaP may be used as a diagnostic tool to identify prognostically relevant sub-classifications of these cancers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/jcp.2006.043810

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 32

  1. 10.3322/canjclin.56.2.106 · DOI · Paper page
  2. Taki, 2006, Chromosomal translocations in cancer and their relevance for therapy., Curr Opin Oncol, 18, 62, 10.1097/01.cco.0000198972.69541.04 · DOI
  3. 10.1038/sj.onc.1208892 · DOI
  4. 10.1002/ajmg.10694 · DOI
  5. 10.1159/000019907 · DOI
  6. 10.1023/A:1015575125780 · DOI · Paper page
  7. 10.1002/(SICI)1097-0045(19990301)38:4<303::AID-PROS6>3.0.CO;2-E · DOI
  8. 10.1038/sj.onc.1208518 · DOI · Paper page
  9. 10.1002/gcc.20329 · DOI · Paper page
  10. 10.1593/neo.06283 · DOI · Paper page
  11. 10.1158/0008-5472.CAN-06-1966 · DOI · Paper page
  12. 10.1158/0008-5472.CAN-06-1482 · DOI · Paper page
  13. 10.1097/01.mou.0000193389.31727.9b · doi:10.1097/01.mou.0000193389.31727.9b
  14. 10.1158/0008-5472.CAN-04-2446 · DOI · Paper page
  15. 10.1158/0008-5472.CAN-03-3998 · DOI · Paper page
  16. 10.1002/gcc.20028 · doi:10.1002/gcc.20028
  17. 10.1073/pnas.0507321103 · DOI · Paper page
  18. 10.1007/s10024-002-0013-1 · doi:10.1007/s10024-002-0013-1
  19. 10.1038/sj.onc.1203762 · DOI · Paper page
  20. 10.1158/0008-5472.CAN-06-0168 · DOI · Paper page
  21. 10.1200/JCO.2005.03.3134 · DOI · Paper page
  22. 10.1200/JCO.2005.02.7987 · doi:10.1200/jco.2005.02.7987
  23. 10.1002/ijc.1526 · doi:10.1002/ijc.1526
  24. 10.1016/S0959-8049(01)00077-6 · DOI
  25. 10.1016/S0378-1119(02)01156-3 · DOI · Paper page
  26. 10.1002/cncr.20243 · doi:10.1002/cncr.20243
  27. 10.1038/sj.onc.1210070 · DOI · Paper page
  28. 10.1038/nature06024 · DOI · Paper page
  29. 10.1158/0008-5472.CAN-06-1986 · DOI · Paper page
  30. 10.1158/0008-5472.CAN-06-1871 · DOI · Paper page
  31. 10.1097/01.ju.0000139993.51181.5d · DOI · Paper page
  32. 10.1158/1078-0432.CCR-06-0067 · DOI · Paper page

Cited by

See all 175

Metadata

Authors
Rajput, A. B., Miller, M. A., De Luca, A., Boyd, N., Leung, S., Hurtado-Coll, A., Fazli, L., Jones, E. C., Palmer, J. B., Gleave, M. E., Cox, M. E., & Huntsman, D. G.
Venue
Journal of Clinical Pathology
Publisher
BMJ
Published
2007-01-26
Volume
60
Issue
11
Pages
1238-1243
ISSN
  • 0021-9746 (ISSN-L)
  • 1472-4146
OpenAlex
W1973206059
Cited by
175
References
1
FWCI
16.14
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers. https://app.cochat.ai/papers/10.1136/jcp.2006.043810
The paper
Rajput, A. B., Miller, M. A., De Luca, A., Boyd, N., Leung, S., Hurtado-Coll, A., Fazli, L., Jones, E. C., Palmer, J. B., Gleave, M. E., Cox, M. E., & Huntsman, D. G. (2007). Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers. Journal of Clinical Pathology. https://doi.org/10.1136/jcp.2006.043810

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.